Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,915 | 2,380 | 2,314 | 3,620 | 4,946 |
| Marketable Securities | 30,464 | 36,687 | 40,628 | 42,792 | 20,751 |
| TOTAL | $49,051 | $39,536 | $43,248 | $46,923 | $26,217 |
| Non-Current Assets | |||||
| PPE Net | 218 | 252 | 289 | 334 | 385 |
| Other Non-Current Assets | 1,121 | 1,207 | 1,292 | 1,378 | 1,492 |
| TOTAL | $1,339 | $1,459 | $1,581 | $1,712 | $1,877 |
| Total Assets | $50,390 | $40,995 | $44,829 | $48,635 | $28,094 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,872 | 1,344 | 1,143 | 1,033 | 1,700 |
| TOTAL | $2,229 | $1,695 | $1,487 | $1,371 | $2,031 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 791 | 882 | 973 | 1,064 | 1,148 |
| TOTAL | $791 | $882 | $973 | $1,064 | $1,148 |
| Total Liabilities | $3,020 | $2,577 | $2,460 | $2,435 | $3,179 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 500 | 380 | 380 | 380 | 380 |
| Retained earnings | -145,626 | -139,984 | -135,028 | -130,036 | -124,387 |
| TOTAL | $47,370 | $38,418 | $42,369 | $46,200 | $24,915 |
| Total Liabilities And Equity | $50,390 | $40,995 | $44,829 | $48,635 | $28,094 |